← Back to Search

Behavioural Intervention

Financial Transfers for Premature Birth

N/A
Waitlist Available
Led By Margaret Parker, MD
Research Sponsored by Harvard School of Public Health (HSPH)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured within one week of discharge form the nicu
Awards & highlights

Study Summary

"This trial aims to test if providing financial support to low-income mothers of premature infants can help them spend more time in the NICU with their babies. The goal is to see if this support can reduce

Who is the study for?
This trial is for low-income mothers with Medicaid who have given birth to preterm infants (24-33 weeks' gestation) at specific hospitals in Massachusetts and Georgia. The study aims to help these mothers spend more time in the NICU with their babies by providing financial support.Check my eligibility
What is being tested?
The trial is testing if weekly financial transfers can increase visits to the NICU, reduce mothers' financial stress, and improve caregiving behaviors that benefit preterm infant health and development. It's a randomized controlled trial comparing usual care plus money versus just usual care.See study design
What are the potential side effects?
There are no direct medical side effects from participating in this study as it involves financial support rather than medical treatment. However, changes in stress levels or behavior due to receiving or not receiving funds could indirectly affect participants.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured monthly from nicu admission to discharge or 42 weeks corrected gestational age, whichever comes earlier (maximum of 18 weeks) and within one week of discharge form the nicu
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured monthly from nicu admission to discharge or 42 weeks corrected gestational age, whichever comes earlier (maximum of 18 weeks) and within one week of discharge form the nicu for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Provision of breast milk (proportion)
Provision of skin-to-skin care
Secondary outcome measures
Accuracy Performance Modified Flanker Task
Accuracy Psychomotor Vigilance Task
Baby emergency department visit between 4-8 weeks post-discharge
+35 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Financial TransfersExperimental Treatment1 Intervention
Mothers assigned to the intervention group will be informed that they are eligible to receive financial transfers $160/week on a "CuddleCard" debit-card with a one- time "label" or scripted message that states: "This money is intended to help you to spend more time visiting and caring for your infant(s) in the NICU." Financial transfers will begin 1 week after birth or when the mother is discharged (whichever comes later) until the infant is discharged, except in cases where the hospitalization lasts beyond 42 weeks corrected age.
Group II: Usual CareActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Harvard School of Public Health (HSPH)Lead Sponsor
273 Previous Clinical Trials
16,305,300 Total Patients Enrolled
6 Trials studying Premature Birth
20,451 Patients Enrolled for Premature Birth
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
1,967 Previous Clinical Trials
2,672,477 Total Patients Enrolled
65 Trials studying Premature Birth
119,090 Patients Enrolled for Premature Birth
Margaret Parker, MDPrincipal InvestigatorUMass Memorial Health

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there several medical facilities within the state conducting this research study?

"The current recruitment drive for this clinical investigation includes notable medical institutions like Boston Medical Center in Boston, Baystate Medical Center in Springfield, and UMass Memorial Medical Center in Worcester. Additionally, there are four more sites participating in patient enrollment."

Answered by AI

Are there current opportunities for individuals to enroll in this research study?

"The details on clinicaltrials.gov indicate that this particular medical study is no longer open for participant enrollment. Initially listed on May 1st, 2024, with the latest update made on April 10th, 2024. Nonetheless, there are currently 313 other trials actively seeking participants."

Answered by AI

What is the primary goal of this medical study?

"The main objective of this research is to assess the provision of skin-to-skin care, from neonatal intensive care unit (NICU) admission until discharge or 42 weeks corrected gestational age, whichever occurs first within a maximum duration of 18 weeks. Secondary endpoints encompass late-onset bacterial or fungal sepsis (LOS), postpartum bonding based on scores obtained through the Postpartum Bonding Questionnaire, and the length of time mothers express milk either by direct breastfeeding or pumping."

Answered by AI
~280 spots leftby May 2028